RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.
作者信息
Ning Baitang, Yu Ai-Ming
机构信息
National Center for Toxicological Research, US Food and Drug Administration (NCTR), 3900 NCTR Road, HFT100, Jefferson, AR 72079, United States.
Department of Biochemistry and Molecular Medicine, UC Davis School of Medicine, 2700 Stockton Blvd, Suite 2130, Sacramento, CA 95817, United States.
出版信息
Biochem Pharmacol. 2021 Jul;189:114567. doi: 10.1016/j.bcp.2021.114567. Epub 2021 Apr 16.
Abstract
摘要
相似文献
1
RNA therapeutics: From biochemical pharmacology to technology development and clinical applications.RNA疗法：从生化药理学到技术开发及临床应用
Biochem Pharmacol. 2021 Jul;189:114567. doi: 10.1016/j.bcp.2021.114567. Epub 2021 Apr 16.
2
[Strategy for technology development of antibody therapeutics].[抗体治疗药物的技术开发策略]
Nihon Yakurigaku Zasshi. 2016 Apr;147(4):235-40. doi: 10.1254/fpj.147.235.
3
"Design for Somebody" - Approach Enabling Mobile Technology Development.“为特定人群设计”——推动移动技术发展的方法
Stud Health Technol Inform. 2017;242:669-675.
4
Science and technology development in Africa needs women.非洲的科技发展需要女性。
Nat Hum Behav. 2020 Dec;4(12):1218. doi: 10.1038/s41562-020-00960-2.
5
Is Heart Failure a High Tech Industrial Giant?心力衰竭是高科技产业巨头吗？
J Card Fail. 2018 Nov;24(11):721-722. doi: 10.1016/j.cardfail.2018.11.009.
6
The Implementation of a Participatory Technology Development Process in a Clinical Setting.参与式技术开发流程在临床环境中的实施。
Stud Health Technol Inform. 2022 Jun 29;295:67-70. doi: 10.3233/SHTI220662.
7
Hitting home with technology development for asthma.通过技术发展助力哮喘防治深入人心。
Lancet Respir Med. 2016 Feb;4(2):102-3. doi: 10.1016/S2213-2600(15)00525-1. Epub 2015 Dec 19.
8
President's message: transcultural nursing and technology: really?主席致辞：跨文化护理与技术：真的吗？
J Transcult Nurs. 2015 May;26(3):336. doi: 10.1177/1043659615571441. Epub 2015 Feb 12.
9
Despite or Due to the Cultural Revolution: The Development of Chinese Science, Technology, and Medicine in the 1960s and 1970s.无论归因于还是归咎于“文化大革命”：20世纪60年代和70年代中国科学、技术与医学的发展
Endeavour. 2017 Sep;41(3):78-84. doi: 10.1016/j.endeavour.2017.06.012. Epub 2017 Jul 29.
10
Four Models to Guide AT Projects Intending Innovative Technology Development Outcomes.指导旨在实现创新技术开发成果的辅助技术项目的四种模式。
Stud Health Technol Inform. 2017;242:421-428.
引用本文的文献
1
The Growing Class of Novel RNAi Therapeutics.新型 RNAi 治疗药物不断增加。
Mol Pharmacol. 2024 Jun 18;106(1):13-20. doi: 10.1124/molpharm.124.000895.
本文引用的文献
1
Small nucleic acids and the path to the clinic for anti-CRISPR.小核酸与抗 CRISPR 走向临床
Biochem Pharmacol. 2021 Jul;189:114492. doi: 10.1016/j.bcp.2021.114492. Epub 2021 Feb 27.
2
Physiologically based pharmacokinetic (PBPK) modeling of RNAi therapeutics: Opportunities and challenges.基于生理学的 RNA 干扰治疗药物药代动力学建模：机遇与挑战。
Biochem Pharmacol. 2021 Jul;189:114468. doi: 10.1016/j.bcp.2021.114468. Epub 2021 Feb 10.
3
Non-coding RNAs: Emerging from the discovery to therapeutic applications.非编码 RNA：从发现到治疗应用的崛起。
Biochem Pharmacol. 2021 Jul;189:114469. doi: 10.1016/j.bcp.2021.114469. Epub 2021 Feb 10.
4
A novel mechanism underlying alcohol dehydrogenase expression: hsa-miR-148a-3p promotes ADH4 expression via an AGO1-dependent manner in control and ethanol-exposed hepatic cells.一种新的酒精脱氢酶表达机制：hsa-miR-148a-3p 通过依赖 AGO1 的方式促进对照和乙醇暴露的肝细胞中 ADH4 的表达。
Biochem Pharmacol. 2021 Jul;189:114458. doi: 10.1016/j.bcp.2021.114458. Epub 2021 Feb 6.
5
Metformin-conjugated micellar system with intratumoral pH responsive de-shielding for co-delivery of doxorubicin and nucleic acid.载阿霉素和核酸的肿瘤内 pH 响应性解屏蔽的聚乙二醇化胶束给药系统
Biochem Pharmacol. 2021 Jul;189:114453. doi: 10.1016/j.bcp.2021.114453. Epub 2021 Feb 3.
6
The growth of siRNA-based therapeutics: Updated clinical studies.基于 siRNA 的治疗药物的发展：更新的临床研究。
Biochem Pharmacol. 2021 Jul;189:114432. doi: 10.1016/j.bcp.2021.114432. Epub 2021 Jan 26.
7
Biochemical features and mutations of key proteins in SARS-CoV-2 and their impacts on RNA therapeutics.SARS-CoV-2 关键蛋白的生化特征和突变及其对 RNA 治疗药物的影响。
Biochem Pharmacol. 2021 Jul;189:114424. doi: 10.1016/j.bcp.2021.114424. Epub 2021 Jan 19.
8
Targeting nucleolin by RNA G-quadruplex-forming motif.靶向核仁素的 RNA G-四链体形成基序。
Biochem Pharmacol. 2021 Jul;189:114418. doi: 10.1016/j.bcp.2021.114418. Epub 2021 Jan 16.
9
Flavonoid display ability to target microRNAs in cancer pathogenesis.类黄酮显示出靶向癌症发病机制中 microRNAs 的能力。
Biochem Pharmacol. 2021 Jul;189:114409. doi: 10.1016/j.bcp.2021.114409. Epub 2021 Jan 8.
10
The N-methyladenosine modification posttranscriptionally regulates hepatic UGT2B7 expression.N6-甲基腺苷修饰在后转录水平上调节肝脏 UGT2B7 的表达。
Biochem Pharmacol. 2021 Jul;189:114402. doi: 10.1016/j.bcp.2020.114402. Epub 2020 Dec 30.
Zotero 插件